Lilly sells Zepbound vials from $299/mo: compare 11 direct-pay programs →
WeighedHealth
Affiliate disclosure: we earn commission from some partners. Learn more.

Foundayo orforglipron

pronounced as (or for glip' ron)

Weight LossBy Eli Lilly· FDA-approved 2026New 2026

Once-daily oral non-peptide GLP-1 for chronic weight management, FDA-approved April 1, 2026. LillyDirect self-pay from $149/month. No injection, no compounded versions.

Foundayo delivery device illustration
Jump to section
Reviewed by the WeighedHealth Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of July 2026; updated when guidance or availability changes.

Foundayo vs Rybelsus

Both are daily oral GLP-1s. Rybelsus is the oral form of semaglutide (peptide, strict fasting rules); orforglipron (Foundayo) is Lilly's non-peptide pill, FDA-approved for weight management in April 2026 and taken with or without food.

FoundayoRybelsus
Generic nameorforglipronsemaglutide (oral)
ManufacturerEli LillyNovo Nordisk
FDA statusFDA-approved 2026FDA-approved 2019
Clinical efficacy11.2% mean body-weight reduction at 72 weeks on the top dose vs 2.1% placebo (ATTAIN-1 Phase 3)—
Pivotal trialATTAIN-1 / ACHIEVE program—
Boxed warningYesYes
Trial participants3,000—
StorageStore oral tablets at room temperature per the product label. Keep in original packaging away from moisture.Store tablets at room temperature in the original blister/bottle, protected from moisture. Keep each tablet sealed until use.
Dosing frequencyonce dailyonce daily, on an empty stomach in the morning, waiting at least 30 minutes before food
Elimination half-lifeapproximately 29 to 49 hours after an oral doseapproximately one week
Full pageFoundayo →Rybelsus →

Deep comparison: Foundayo vs Rybelsus →

What is Foundayo?

Orforglipron (brand name Foundayo) is Eli Lilly's once-daily oral non-peptide GLP-1 receptor agonist, FDA-approved April 1, 2026 for chronic weight management. Unlike semaglutide (which requires either injection or a tightly-dosed oral peptide), orforglipron is a small molecule that survives digestion, so it can be taken as a simple daily pill without the strict fasting-and-water rules that oral semaglutide (Rybelsus) demands. It can be taken with or without food, and LillyDirect self-pay starts at $149/month. There are no compounded versions, because it is a novel patented molecule.

How does Foundayo work?

Same target as injectable GLP-1s — the GLP-1 receptor — but a non-peptide small-molecule structure. Activates GLP-1 signaling to slow gastric emptying, suppress appetite, and improve glycemic control. The oral, digestion-stable chemistry is the breakthrough: it expands GLP-1 therapy to patients who refuse injections.

Who can take Foundayo?

Adults with obesity, or overweight with at least one weight-related condition, for chronic weight management. Not approved for type 2 diabetes. Especially relevant for needle-averse patients who declined injectable GLP-1s. Same thyroid C-cell contraindication class as other GLP-1s.

How is Foundayo taken?

Once-daily oral tablet, titrated upward over several weeks to manage GI side effects. Taken with or without food, at any time of day (unlike Rybelsus, which requires an empty stomach).

How much does Foundayo cost?

LillyDirect self-pay: $149/month for 0.8 mg and 2.5 mg, $199 for 5.5 mg, and $299 for 9 mg, 14.5 mg, and 17.2 mg. The 2.5 mg and 5.5 mg prices are introductory through December 31, 2026; the 14.5 mg and 17.2 mg price requires a refill within 45 days. With commercial insurance that covers it, the Foundayo savings card can lower the cost to as little as $25/month (savings capped at $100/month, through December 31, 2026). Medicare GLP-1 Bridge: $50/month from July 1, 2026 to December 31, 2027.

What side effects can Foundayo cause?

GI side effects typical of the GLP-1 class: nausea, diarrhea, constipation, vomiting, especially during titration. Trial tolerability broadly comparable to injectable GLP-1s.

What if I miss a dose of Foundayo?

Once-daily dosing. If a dose is missed, take it the same day if remembered; skip if it is nearly the next day. Do not double up.

How should Foundayo be stored?

Store oral tablets at room temperature per the product label. Keep in original packaging away from moisture.

What if I overdose on Foundayo?

Orforglipron is a non-peptide oral GLP-1; specific overdose data is limited. As with the injectable GLP-1s there is no specific antidote, and the same general approach applies: call US Poison Control at 1-800-222-1222 immediately, or go to the ER for severe hypoglycemia, persistent vomiting, dehydration, or altered mental status. The shorter daily-pill half-life means recovery should be faster than the weekly injectables, but supportive care is still required.

Related terms

Related topics

How to get it

  1. Take the eligibility quiz

    5 minutes of medical-history questions matched to the medication's FDA criteria. Free, no commitment.

  2. Submit ID + a recent photo

    Required by every legitimate US telehealth platform to verify identity and meet state prescribing rules.

  3. Async clinical review

    A licensed clinician in your state reviews your history and decides whether the medication is appropriate. Typically within 24-48 hours.

  4. Prescription ships

    If approved, the medication is sent from a partner pharmacy. Initial titration dose arrives in 3-7 days for most US states.

  5. Ongoing support

    Most programs include follow-up check-ins, dose adjustments, and side-effect support. Coverage varies by program.

Sources

Primary references this page draws from. We cite original sources so you can verify any claim.

  1. ManufacturerEli Lilly: FDA approves Foundayo (orforglipron)
  2. ManufacturerFoundayo prescribing information
  3. Clinical trialOrforglipron Phase 3 ATTAIN/ACHIEVE program (ClinicalTrials.gov)

More on Foundayo

For clinicians: see the Foundayo prescribing summary.

Share: